NC-6004

cisplatin nanoparticle formulation · NanoCarrier Co., Ltd.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for NC-6004, covering 2019-04-29 to 2025-01-22. Get the full timeline:

Most recent: Clinical Trial Update: Combination Therapy With NC-6004 and Gemcitabine in Advanced Solid Tumors or Non-Small Cell Lung, Biliary and Bladder Cancer [Phase 1, Phase 2]

See pricing